- Home
- Publications
- Publication Search
- Publication Details
Title
Cardioprotection by SGLT2 Inhibitors—Does It All Come Down to Na+?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 15, Pages 7976
Publisher
MDPI AG
Online
2021-07-27
DOI
10.3390/ijms22157976
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study
- (2021) Matthias Rau et al. Cardiovascular Diabetology
- Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
- (2021) Hang-Long Li et al. Cardiovascular Diabetology
- Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions
- (2021) Coert J Zuurbier et al. CARDIOVASCULAR RESEARCH
- The Cardiac Late Sodium Channel Current is a Molecular Target for the Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin
- (2021) Koenraad Philippaert et al. CIRCULATION
- Empagliflozin Inhibits Proximal Tubule NHE3 Activity, Preserves GFR, and Restores Euvolemia in Nondiabetic Rats with Induced Heart Failure
- (2021) Flávio A. Borges-Júnior et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
- (2021) Scott D. Solomon et al. EUROPEAN JOURNAL OF HEART FAILURE
- Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure
- (2020) Hidekazu Tanaka et al. Cardiovascular Diabetology
- Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial
- (2020) Thomas A. Zelniker et al. CIRCULATION
- The Control of Diastolic Calcium in the Heart
- (2020) David A. Eisner et al. CIRCULATION RESEARCH
- Different effects of SGLT2 inhibitors according to the presence and types of heart failure in type 2 diabetic patients
- (2020) In-Chang Hwang et al. Cardiovascular Diabetology
- Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
- (2020) Detmar Kolijn et al. CARDIOVASCULAR RESEARCH
- Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents
- (2020) Balázs Horváth et al. Frontiers in Pharmacology
- CaMKII and GLUT1 in heart failure and the role of gliflozins
- (2020) M. Trum et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study
- (2020) Hung-Yi Chen et al. Cardiovascular Diabetology
- Contribution of the neuronal sodium channel NaV1.8 to sodium- and calcium-dependent cellular proarrhythmia
- (2020) Philipp Bengel et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium
- (2020) Donato Cappetta et al. PHARMACOLOGICAL RESEARCH
- Inhibition of cardiac potassium currents by oxidation-activated protein kinase A contributes to early afterdepolarizations in the heart
- (2020) Maximilian Josef Trum et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
- (2020) Maria del Carmen Asensio Lopez et al. Scientific Reports
- Empagliflozin inhibits Na + /H + exchanger activity in human atrial cardiomyocytes
- (2020) Maximilian Trum et al. ESC Heart Failure
- Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR‐Preserved Trial
- (2020) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
- (2020) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure
- (2020) Carlos G. Santos-Gallego et al. JACC-Cardiovascular Imaging
- Delayed ischemic contracture onset by Empagliflozin associates with NHE-1 inhibition and is dependent on insulin in isolated mouse hearts
- (2019) Laween Uthman et al. CARDIOVASCULAR RESEARCH
- Cardiac sodium-dependent glucose cotransporter 1 is a novel mediator of ischaemia/reperfusion injury
- (2019) Zhao Li et al. CARDIOVASCULAR RESEARCH
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload
- (2019) Lin Shi et al. AMERICAN JOURNAL OF HYPERTENSION
- Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction
- (2019) Salva R. Yurista et al. EUROPEAN JOURNAL OF HEART FAILURE
- CaMKII Activity in the Inflammatory Response of Cardiac Diseases
- (2019) Maria Rosaria Rusciano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
- (2019) Qingmiao Shao et al. Cardiovascular Diabetology
- SERCA2a: a key protein in the Ca2+ cycle of the heart failure
- (2019) Liu Zhihao et al. HEART FAILURE REVIEWS
- Pretreatment with KGA-2727, a selective SGLT1 inhibitor, is protective against myocardial infarction-induced ventricular remodeling and heart failure in mice
- (2019) Yohei Sawa et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
- (2018) Daisuke Matsutani et al. Cardiovascular Diabetology
- Afterdepolarizations and triggered activity as a mechanism for clinical arrhythmias
- (2018) Andrew L. Wit PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
- (2018) Trygve S. Hall et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats
- (2018) Aysegul Durak et al. Cardiovascular Diabetology
- German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management
- (2018) Dierk Thomas et al. Clinical Research in Cardiology
- Empagliflozin directly improves diastolic function in human heart failure
- (2018) Steffen Pabel et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes
- (2018) Ferdinando Carlo Sasso et al. Journal of Diabetes Research
- Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target
- (2017) Alessandra Di Franco et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart
- (2017) Anne Van Steenbergen et al. Scientific Reports
- Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?
- (2016) Subodh Verma et al. DIABETES CARE
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction
- (2016) Uwe Primessnig et al. EUROPEAN JOURNAL OF HEART FAILURE
- Overproduction of reactive oxygen species and activation of MAPKs are involved in apoptosis induced by PM2.5in rat cardiac H9c2 cells
- (2015) Jing Cao et al. JOURNAL OF APPLIED TOXICOLOGY
- Na+/Ca2+exchange and Na+/K+-ATPase in the heart
- (2015) Michael J. Shattock et al. JOURNAL OF PHYSIOLOGY-LONDON
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intracellular Na+Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+–Glucose Cotransport
- (2015) Rebekah Lambert et al. Journal of the American Heart Association
- Intracellular Na+ overload causes oxidation of CaMKII and leads to Ca2+ mishandling in isolated ventricular myocytes
- (2014) Serge Viatchenko-Karpinski et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- NADPH oxidase 2 mediates angiotensin II-dependent cellular arrhythmias via PKA and CaMKII
- (2014) Stefan Wagner et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats
- (2014) Atsuo Tahara et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- CaMKII-dependent regulation of cardiac Na+ homeostasis
- (2014) Eleonora Grandi et al. Frontiers in Pharmacology
- The arrhythmogenic consequences of increasing late INa in the cardiomyocyte
- (2013) John C. Shryock et al. CARDIOVASCULAR RESEARCH
- Sgk1-Dependent Stimulation of Cardiac Na+/H+Exchanger Nhe1 by Dexamethasone
- (2013) Jakob Voelkl et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30-50% of Filtered Glucose Load in Humans
- (2013) M. A. Abdul-Ghani et al. DIABETES
- Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice
- (2013) Atsuo Tahara et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Na+ transport in the normal and failing heart — Remember the balance
- (2013) Sanda Despa et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Intracellular Na+ and cardiac metabolism
- (2013) Johannes Bay et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease
- (2013) Karl Toischer et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction
- (2012) Nazha Hamdani et al. CARDIOVASCULAR RESEARCH
- Ca 2+ /Calmodulin-Dependent Protein Kinase II–Based Regulation of Voltage-Gated Na + Channel in Cardiac Disease
- (2012) Olha M. Koval et al. CIRCULATION
- Ranolazine Decreases Mechanosensitivity of the Voltage-Gated Sodium Ion Channel Na V 1.5
- (2012) Arthur Beyder et al. CIRCULATION
- Redox Signaling in Cardiac Physiology and Pathology
- (2012) Joseph R. Burgoyne et al. CIRCULATION RESEARCH
- Blocking Scn10a Channels in Heart Reduces Late Sodium Current and Is Antiarrhythmic
- (2012) Tao Yang et al. CIRCULATION RESEARCH
- Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) Regulates Cardiac Sodium Channel NaV1.5 Gating by Multiple Phosphorylation Sites
- (2012) Nicole M. Ashpole et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- About half of the late sodium current in cardiac myocytes from dog ventricle is due to non-cardiac-type Na+ channels
- (2012) Michael Biet et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Transient outward K+current reduction prolongs action potentials and promotes afterdepolarisations: a dynamic-clamp study in human and rabbit cardiac atrial myocytes
- (2012) A. J. Workman et al. JOURNAL OF PHYSIOLOGY-LONDON
- Persistent sodium current and Na+/H+ exchange contributes to the augmentation of the reverse Na+/Ca2+ exchange during hypoxia or acute ischemia in ventricular myocytes
- (2012) Qiong Tang et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reactive Oxygen Species–Activated Ca/Calmodulin Kinase IIδ Is Required for Late I Na Augmentation Leading to Cellular Na and Ca Overload
- (2011) Stefan Wagner et al. CIRCULATION RESEARCH
- Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
- (2011) R. Grempler et al. DIABETES OBESITY & METABOLISM
- Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase
- (2011) Ali El-Armouche et al. FASEB JOURNAL
- Tight Glycemic Control May Increase Regenerative Potential of Myocardium during Acute Infarction
- (2011) Raffaele Marfella et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Is CaMKII a link between inflammation and hypertrophy in heart?
- (2011) Madhu V. Singh et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels
- (2011) Stephan A. Pless et al. Nature Communications
- Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIδC can be reversed by inhibition of late Na+ current
- (2010) Samuel Sossalla et al. BASIC RESEARCH IN CARDIOLOGY
- Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation
- (2010) Simon Sedej et al. CARDIOVASCULAR RESEARCH
- Elevated Cytosolic Na + Increases Mitochondrial Formation of Reactive Oxygen Species in Failing Cardiac Myocytes
- (2010) Michael Kohlhaas et al. CIRCULATION
- A βIV-spectrin/CaMKII signaling complex is essential for membrane excitability in mice
- (2010) Thomas J. Hund et al. JOURNAL OF CLINICAL INVESTIGATION
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
- (2010) Jian Chen et al. Diabetes Therapy
- SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states
- (2009) S. K. Banerjee et al. CARDIOVASCULAR RESEARCH
- Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart
- (2009) Madhu V. Singh et al. JOURNAL OF CLINICAL INVESTIGATION
- Ca2+/calmodulin-dependent protein kinase II contributes to intracellular pH recovery from acidosis via Na+/H+ exchanger activation
- (2009) Martín Vila-Petroff et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Late Na+ current produced by human cardiac Na+ channel isoform Nav1.5 is modulated by its β1 subunit
- (2009) Victor A. Maltsev et al. Journal of Physiological Sciences
- The isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload
- (2009) J. Backs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts — Role of late sodium current and intracellular ion accumulation
- (2008) Samuel Sossalla et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Electrostatic Contributions of Aromatic Residues in the Local Anesthetic Receptor of Voltage-Gated Sodium Channels
- (2007) Christopher A. Ahern et al. CIRCULATION RESEARCH
- Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action
- (2006) Sandra Fredj et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started